Kezar Life Sciences, Inc. announced that on April 21, 2023, Christopher Kirk, Ph.D. resigned from his role as President and Chief Scientific Officer of athe company. Dr. Kirk remains a member of the Board of Directors of the Company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.714 USD | -2.00% | -7.13% | -24.94% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.94% | 53.04M | |
+12.13% | 116B | |
+12.52% | 106B | |
-10.05% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.59% | 16.33B | |
+6.10% | 14.14B | |
+29.70% | 12.02B |
- Stock Market
- Equities
- KZR Stock
- News Kezar Life Sciences, Inc.
- Kezar Life Sciences, Inc. Announces Resignation of Christopher Kirk as President and Chief Scientific Officer